Arterium presents motion sickness medication
Arterium Corporation has presented a new product in Uzbekistan—Dramina motion sickness pills. The medicinal product's active ingredient is dimenhydrinate. Its purpose is to relieve motion sickness symptoms like dizziness, nausea, and vomiting in children and adults. Dramina quickly relieves symptoms of motion sickness, from which statistically every 6th adult and every 4th child suffers. Inducing histamine receptor blockade, the product exhibits anti-nauseant, anti-emetic, sedative, and anti-allergic action, as well as mitigates dizziness. Arterium Corporation exclusively markets Dramina in the Uzbek market as part of its partnership with Croatia's JDL.